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Nowadays, the pharmaceutical industry faces the challenge of
innovating and increasing the productivity of new medicines
due to the increasing multidrug resistance among bacteria,
viruses and fungi. The main objective of the present study is
connected quinolone and triazole molecules to enhance and
broad antibacterial spectrum as well as to have multiple
mechanisms of action. Preparation of 4-substituted-1H-1,2,3-
triazol-1-yl in C-7 of 6-fluoro- and 6,8-difluoro-quinolone ring is
showed. The synthesis involved the preparation of intermediate
ethyl 7-azide-1-ethyl-fluoroquinolone-3-carboxylate, followed
by copper(I)-catalyzed azide-alkyne cycloaddition to give 13
derivatives. The cycloaddition was carried out by two different
methods, where it was observed that the microwave radiation
was the best reaction condition, obtaining a range of yields of
47–93%, at 140 °C, 125Wmax for 10 minutes. Therefore, this
methodology provided an easy pathway to synthesize a library
of fluoroquinolones coupled to 1,2,3-triazole, still unexplored.
Introduction
Quinolones and its derivatives form an important class of
compounds, which are widely used in medicine, mainly as
antibacterial agents, but also as antidiabetic, antitumor, anti-
tubercular, antimalarial, antiviral, and anti-HIV agents,[1-6] as a
result of activity, significant tissue penetration, and convenient
routes of administration. Intense research for potent fluoroqui-
nolone derivatives has been possible due to modifications in
the quinolone nucleus through the addition of different
substituents at the N-1, C-5, C-6, C-7, and C-8, and the
formation of fused rings, between the 5 and 6, 6 and 7, or 7
and 8 positions.[7,8] The most successful compounds developed
are based on modifications at C-7, and it has been found that
the spectrum, level of antibacterial activity, inhibition of DNA
gyrase or topoisomerase IV, and cell permeability are highly
affected by the nature of the C-7 substituent group. Substitu-
ents that have been studied included: medium-sized N-
heterocyclic ring (5- and 6-membered),[9,10] N-substituted
piperazine,[11,12] linear substituents with one or two heteroa-
toms (-NHNH2, -NHR, -NHCH2CH2NH2), methyl-, chloro-, and
1,2,3-triazole-derivatives.[13-18] The 1,2,3 moiety does not occur
in nature, although the synthetic molecules containing 1,2,3-
triazole unit show diverse biological activities including anti-
obesity, antiallergic, antibacterial, antiparasitic, herbicidal, fun-
gicidal, and anti-HIV.[19-23] 1,2,3-triazole moieties are stable to
metabolic degradation, oxidative/reductions conditions, and
are capable of dipole-dipole interactions and hydrogen bond-
ing, which can be favourable in the binding of biomolecular
targets and for solubility.[24,25]
In order to cover those exploratory biological needs, a
strategy of synthesis of triazole-fluoroquinolone pharmaco-
phore library that involve a low time of reaction, good yields
without use of inert atmosphere, and minimal purification, is
required. The purpose of this investigation is to provide a more
advantageous method for the synthesis of 7-(4-substituted-1H-
1,2,3-triazol-1-yl)-fluoroquinolones. The derivatives were pre-
pared by conventional as well as microwave irradiation.
Results and Discussion
The copper-catalyzed azide-alkyne cycloaddition (CuAAC) reac-
tion is well suited to many solution-phase applications with the
simple use of Cu(I) salts, either added directly or generated by
reduction of Cu(II) or oxidation of Cu(0).[26] The reaction is
quantitative, regioselective, thermodynamic and kinetically
favorable. On preliminary results, the ethyl 7-azide-1-ethyl-6,8-
difluoroquinolone-3-carboxylate 1, and ethyl 7-azide-1-ethyl-6-
fluoroquinolone-3-carboxylate 2 were prepared from 2,3,4-
trifluoro-, or 3,4-difluoro-aniline, according to the literature
method.[27] Azide fluoroquinolone 1, was first synthesized and
used for the CuAAC by CuI and NaOH (0.5 N).[28, 29] The Cu(I)
species may either be introduced as performed complexes, but
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these conditions did not generate favorable results, even when
a variety of solvents (MeOH, CH3CN, DMSO, DMF, H2O/acetone,
H2O/CH3CN) were used in combination with other bases as
DIPEA or TEA, or when the temperature was increased to
140 °C.[26] It is possible that the poor stability of CuI and its rapid
oxidation to CuII does not allow catalyzed the cycloaddition
reaction,[30, 31] which led to the fluoroquinolone azide being
easily broken with the irreversible loss of N2, producing singlet
nitrene that generated secondary products by selective O@H or
N@H insertion with CH3OH or DEA respectively or proton
abstraction.[32] However, triazole ring was obtained when the
catalyst CuI was exchanged for a mixture of CuSO4 and sodium
ascorbate in solid form, obtaining low yields (Table 1, entry 2);
but when catalyst was used in a solution system, CuSO4 (1 M)
and sodium ascorbate (7.5%),[33-35] the yields increased to 80%
with 5 days of reaction (Table 1, entry 3). On the other hand,
temperatures below 50 °C did not proceed, temperatures above
it were not made to prevent the formation of nitrene group in
the quinolone ring by thermolysis. When the reaction time was
extended to 10 days, no differences in yields were observed.
Furthermore, the strategy of synthesis of a series of 7-(4-
substituted)-triazolyl-6,8-difluoroquinolones by CuAAC reaction
(table 3) was possible in medium efficiency and a simple work-
up procedure. With a one-pot reaction starting from the
appropriate azide 1 and alkyne-derivative 3a-j, the Cu(I)
catalyst was prepared in situ by copper sulphate (II) and sodium
ascorbate. After heating the reaction mixture at 50 °C for one
weak in DMF, the triazole product 4a-i was isolated by simple
filtration and recrystallization with CH3CN and yields ranging
from 41% to 78%. The structures of triazole 4a-i obtained, were
confirmed by lack of the band in 2127 cm@1 of N3 and the
increment of bands in the region of 1620 to 1450 cm@1 due to
aromatic and triazole C=C bonds. The stretching absorptions
bands for C@N appeared as multiple bands around 1300 to
1000 cm@1 in the IR spectrum. The 1HNMR spectra exhibited a
single peak between 8.68 and 7.83 ppm, and the 13CNMR
spectra showed two signals in the range of 156.60-151.06 and
136.60-122.02 ppm for the triazolinic ring. Compound 5j could
not characterize by 13CNMR due to its low solubility in DMSO-
d6.
The fragmentation pattern of the synthesized triazole-
fluoroquinolone, showed the formation of several ions, which
were generated through elimination of C2H4 (transforming ester
to carboxylic acid), as well as the loss of CO2, CO, OH, C2H4 (in
N-1 position), and in some cases (4a, 4b, 4 i, 5g), the triazole
ring was disrupted into azide-fluoroquinolone. This triazole ring
fragmentation is consistent with the retro-cycloaddition 1,3-
dipolar reaction observed under ultrasonic or ultraviolet
conditions.[36, 37]
Microwave radiation was used as an alternative route
proposed to a drastic reduction in the reaction time, minimize
cumbersome work-up, and get better yield.[38-40] Microwave
radiation uses relatively low energy that is non-ionizing and
cannot break chemical bonds; it can only make molecules
rotate. Conventional heating is slow, relying on convection
currents and thermal conductivity, whereas microwave heating
is fast and occurs on a molecular level. In the preliminary
proofs, the 50 °C was maintained as maximum temperature to
avoid decomposition of azide group, situations in which the
formation of triazole was not achieved when was used solvent
such as toluene, n-hexane, and even free solvent conditions
(use of phenylacetylene as reactant and solvent).[39] High
temperatures such as 78 °C allowed a 25% yield in 10 minutes
with DMF, but potency during the reaction decreased to 20 W.
However, conditions of 125Wmax, 140 °C, and 10 minutes
allowed a yield of 80% (Table 2).
Use of protic solvents increased the synthesis of by-
products, while CH3CN with close vessel and automatic control
of pressure, showed a 54% yield without further purifications
(table 2, entry 5), which allows to explore the reaction and
modify just the time interval, increasing the yields of 4a-i and
5g-j when the radiation is used for 2 minutes, then cooling, 2
minutes then cooling, and 2 minutes then cooling.
Thus, the synthesis of several triazole-quinolones 4a-i and
5g-j was achieved under microwave heat in good yields,
ranging between 47 to 93% (Table 3), and decreasing the
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Table 2. Microwave-assisted for the synthesis of 7-triazol-1-yl-fluoroquino-
lone by CuAAC.
Entry Solvent T (°C) t (min) Yield (%)
1 DMF 80 10 25
2 DMF 140 20 81
3 DMF 140 10 80
4 CH3CN 80 10 50
5 CH3CN 140 10 54
6 EtOH 80 10 - -
[a] CuSO4⋅7H2O in solution of 1 M (5%mol), Na-Asc in solution at 7.5% (20%
mol), were used.
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reaction time from a week to 10 minutes. In comparison of
fluoroquinolones-triazole linked by piperazine or bicycle ring,[41-
43] where the effect of substituents in azido group, are not
appreciative, the yields obtained here were similar to the
reported in the literature, from 72 to 82%; the use of inert
atmospheres[43] or further purifications like chromatographic
column[44] were unnecessary, only a simple recrystallization was
performed in CH3CN, avoiding the use of special equipment.
Conclusions
In conclusion, a series of 7-(4-substituted-triazolyl)-quinolones
was synthesized by Cu(I)-catalyzed azide/alkyne cycloaddition
reaction under heating at 50 °C for one week or microwave-
assisted (125Wmax, 140 °C and 10 minutes) with mild conditions,
presenting good yields and less reaction time.
Supporting Information Summary
The azide-fluoroquinolone 1 or 2 (328.6 μmol) was mixed with
the alkyne 3a-j (492.9 μmol, except prop-2-yn-1-ol of g: 328.6
μmol), CuSO4⋅7H2O 1 M (65.7 μmol) and sodium ascorbate at
7.5% (16.4 μmol) into 3 mL of DMF at 50 °C for 5 days; or
microwave conditions: 125Wmax, 140 °C, 10 minutes with 3 mL
of DMF for alkynes 3a-d and 3j, or 3 mL of CH3CN (using
automatic control of pressure) for the alkynes 3e-i. The brown
solution obtained after this time (in both cases) was poured
into an ice bath and 10 mL of ice water was added. The
precipitate obtained was separated and dried by vacuum
filtration. The structure of the compounds 4a-i and 5g-j were
confirmed by 1H and 13CNMR, FTIR and MS analyses.
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